Trials / Unknown
UnknownNCT03239535
Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Federal Research Clinical Center of Federal Medical & Biological Agency, Russia · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The clinical trial aims to study the safety and efficacy of adult allogeneic mesenchymal stem cells for the treatment of critical limb ischemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Mesenchymal stem cells | Intramuscular injection |
| BIOLOGICAL | Normal saline | Intramuscular injection |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2018-08-01
- Completion
- 2018-11-01
- First posted
- 2017-08-04
- Last updated
- 2017-08-04
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT03239535. Inclusion in this directory is not an endorsement.